Page 4 - Nasdaq Tern News Today

BMO Capital Markets started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research note released on Monday morning, The Fly reports. The brokerage issued an outperform rating and a $18.00 target price on the stock. Several other equities analysts have also recently weighed in on the stock. JPMorgan Chase & Co. […]

Monashee Investment Management LLC bought a new stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 122,500 shares of the company’s stock, valued at approximately $1,247,000. Monashee Investment Management LLC owned 0.33% of Terns Pharmaceuticals at […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating) hit a new 52-week high on Wednesday . The stock traded as high as $13.06 and last traded at $13.02, with a volume of 182770 shares changing hands. The stock had previously closed at $12.09. Wall Street Analyst Weigh In Several equities analysts have recently weighed in on […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating)’s share price traded up 4.9% during trading on Thursday . The stock traded as high as $11.66 and last traded at $11.57. 277,276 shares were traded during mid-day trading, a decline of 17% from the average session volume of 332,730 shares. The stock had previously closed at $11.03. […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) had its price objective hoisted by HC Wainwright from $7.00 to $11.00 in a research report released on Wednesday morning, The Fly reports. HC Wainwright currently has a neutral rating on the stock. HC Wainwright also issued estimates for Terns Pharmaceuticals’ Q1 2023 earnings at ($0.30) EPS, Q2 2023 […]

JMP Securities reissued their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $17.00 target price on the stock. TERN has been the subject of a number of other research reports. The Goldman Sachs Group upped their […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) had its target price increased by JPMorgan Chase & Co. from $6.00 to $9.00 in a research report report published on Wednesday morning, Benzinga reports. The firm currently has a neutral rating on the stock. A number of other equities research analysts have also issued reports on the company. […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) and Phibro Animal Health (NASDAQ:PAHC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Insider & Institutional Ownership 49.2% of Phibro Animal […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) had its price target raised by analysts at HC Wainwright from $7.00 to $11.00 in a note issued to investors on Wednesday, The Fly reports. HC Wainwright’s price target indicates a potential upside of 2.90% from the company’s current price. A number of other analysts have also weighed in […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) issued its quarterly earnings data on Monday. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.40) by $0.11, MarketWatch Earnings reports. Terns Pharmaceuticals Stock Up 5.8 % Terns Pharmaceuticals stock opened at $9.44 on Tuesday. The stock’s 50 day moving average is […]